These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24637698)

  • 21. Stability of Meropenem After Reconstitution for Administration by Prolonged Infusion.
    Fawaz S; Barton S; Whitney L; Swinden J; Nabhani-Gebara S
    Hosp Pharm; 2019 Jun; 54(3):190-196. PubMed ID: 31205331
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative in vitro antimicrobial potency, stability, colouration and dissolution time of generics versus innovator of meropenem in Europe.
    Delattre IK; Briquet C; Wallemacq P; Tulkens PM; Van Bambeke F
    Int J Antimicrob Agents; 2020 Jan; 55(1):105825. PubMed ID: 31634551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incompatibility of ciprofloxacin and meropenem injections.
    Chen LY; Chen J; Waters V; Boodhan S
    Am J Health Syst Pharm; 2013 Nov; 70(22):1966, 1970. PubMed ID: 24173004
    [No Abstract]   [Full Text] [Related]  

  • 24. Stability and compatibility of minocycline hydrochloride and rifampin in intravenous solutions at various temperatures.
    Pearson SD; Trissel LA
    Am J Hosp Pharm; 1993 Apr; 50(4):698-702. PubMed ID: 8470688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stability of a 1 beta-methylcarbapenem antibiotic, meropenem (SM-7338) in aqueous solution.
    Takeuchi Y; Sunagawa M; Isobe Y; Hamazume Y; Noguchi T
    Chem Pharm Bull (Tokyo); 1995 Apr; 43(4):689-92. PubMed ID: 7600618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An investigation of the stability of meropenem in elastomeric infusion devices.
    Foy F; Luna G; Martinez J; Nizich Z; Seet J; Lie K; Sunderland B; Czarniak P
    Drug Des Devel Ther; 2019; 13():2655-2665. PubMed ID: 31447546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.
    Roberts JA; Kirkpatrick CM; Roberts MS; Robertson TA; Dalley AJ; Lipman J
    J Antimicrob Chemother; 2009 Jul; 64(1):142-50. PubMed ID: 19398460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbiological equivalence of serum bacteriostatic and bactericidal activities of the sera from healthy volunteers receiving original meropenem (Meronem) and generic meropenem (Mero).
    Thamlikitkul V; Tiengrim S; Chalermsri C; Chinsawangwatanakul P; Suddhichupaiboon S
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S110-6. PubMed ID: 20364565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of in vitro serial antibiotic elution from meropenem-impregnated polymethylmethacrylate beads after ethylene oxide gas and autoclave sterilization.
    Báez LA; Langston C; Givaruangsawat S; McLaughlin R
    Vet Comp Orthop Traumatol; 2011; 24(1):39-44. PubMed ID: 21103653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability, compatibility and microbiological activity studies of meropenem-clavulanate potassium.
    Cielecka-Piontek J; Szymanowska-Powałowska D; Paczkowska M; Łysakowski P; Zalewski P; Garbacki P
    J Antibiot (Tokyo); 2015 Jan; 68(1):35-9. PubMed ID: 25074659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring of effectiveness and safety of generic formulation of meropenem for treatment of infections at Siriraj Hospital.
    Angkasekwinai N; Werarak P; Chaiyasoot K; Thamlikitkul V
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S217-24. PubMed ID: 21721450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compatibility of imipenem-cilastatin sodium with commonly used intravenous solutions.
    Bigley FP; Forsyth RJ; Henley MW
    Am J Hosp Pharm; 1986 Nov; 43(11):2803-9. PubMed ID: 3467590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of Serratia marcescens meningitis with prolonged infusion of meropenem.
    Nicasio AM; Quintiliani R; DeRyke CA; Kuti JL; Nicolau DP
    Ann Pharmacother; 2007 Jun; 41(6):1077-81. PubMed ID: 17472997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overcoming stability challenges during continuous intravenous administration of high-dose amoxicillin using portable elastomeric pumps.
    Binson G; Grignon C; Le Moal G; Lazaro P; Lelong J; Roblot F; Venisse N; Dupuis A
    PLoS One; 2019; 14(8):e0221391. PubMed ID: 31419268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical pharmacokinetics of meropenem in pancreatic juice and site-specific pharmacodynamic target attainment against Gram-negative bacteria: dosing considerations.
    Kondo N; Ikawa K; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Ohge H; Morikawa N; Sueda T
    Pancreatology; 2014; 14(2):95-9. PubMed ID: 24650961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stability of meropenem in a portable infusion device in a cold pouch.
    Grant EM; Zhong MK; Ambrose PG; Nicolau DP; Nightingale CH; Quintiliani R
    Am J Health Syst Pharm; 2000 May; 57(10):992-5. PubMed ID: 10832500
    [No Abstract]   [Full Text] [Related]  

  • 38. Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections.
    Falagas ME; Rafailidis PI; Kasiakou SK; Hatzopoulou P; Michalopoulos A
    Clin Microbiol Infect; 2006 Dec; 12(12):1227-30. PubMed ID: 17121631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of meropenem stability after reconstitution: the influence of buffering and challenges to meet the NHS Yellow Cover Document compliance for continuous infusions in an outpatient setting.
    Jamieson C; Allwood MC; Stonkute D; Wallace A; Wilkinson AS; Hills T;
    Eur J Hosp Pharm; 2020 Mar; 27(e1):e53-e57. PubMed ID: 32296506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of the stability of ertapenem and meropenem in pharmaceutical preparations in solid state.
    Cielecka-Piontek J; Zajac M; Jelińska A
    J Pharm Biomed Anal; 2008 Jan; 46(1):52-7. PubMed ID: 17936535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.